featured
Effect of Dapagliflozin as an Adjunct to Insulin Over 52 Weeks in T1DM
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Dapagliflozin as an Adjunct to Insulin Over 52 Weeks in Individuals With Type 1 Diabetes: Post-Hoc Renal Analysis of the DEPICT Randomised Controlled Trials
Lancet Diabetes Endocrinol 2020 Oct 01;8(10)845-854, PH Groop, P Dandona, M Phillip, P Gillard, S Edelman, J Jendle, J Xu, MF Scheerer, F Thoren, N Iqbal, E Repetto, C MathieuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.